AHIMA launch new EU collaboration in AI and Telehealth.

The American Health Information Management Association (AHIMA) and Frontiers Health, along with  the Healthware Group, recently agreed to a content collaboration that will serve health care professionals in both Europe and the United States.

It comes just prior to the launch of the annual AHIMA Conference, this time Virtual, in just 10 days time. (We will be talking with Michael Bittner, AHIMA Media Director, early next week, on  the key notes to be covered)  In meantime – What they say is this:

“Frontiers Health is recognized across Europe as a transformative organization with a long history of promoting innovation in health care,” said AHIMA CEO Wylecia Wiggs Harris, PhD, CAE. “Like AHIMA, they see the human behind health information and health policy, making our collaboration a natural fit.”

Frontiers Health, in cooperation with Healthware Group, is hosting two education sessions, focusing on telehealth and artificial intelligence in health care, at the AHIMA20 Virtual Conference taking place October 14-17. The sessions will feature speakers from companies like CarePredict, Intouch Group, Kaia Health, Vitality, and Wysa, as well as other global players from the digital health space.

In addition, both organizations will collaborate on sessions at the Frontiers Health Hybrid Conference this November. AHIMA’s international team will host several sessions within an overarching theme of “Data Driving the Future of Health.” AHIMA experts will discuss data consent, privacy, interoperability, patient access to their health information, and more.

“This collaboration serves AHIMA members and health care professionals in Europe, as both groups will have access to new content and resources with a global perspective,” Harris said. “It will also help AHIMA increase its international footprint and reach health care audiences around the world.”

“I am pleased to expand our collaboration with AHIMA and look forward to hosting two dedicated Frontiers Health sessions at the AHIMA20 Virtual Conference,” said Roberto Ascione, conference chairman of Frontiers Health and CEO & founder at Healthware Group. “Frontiers Health will share its extensive knowledge and first-hand experience in strategic spaces like telehealth and artificial intelligence. Through its cooperation with AHIMA, Frontiers Health will promote and contribute to the pivotal role of digital health innovation in the new normal.”

Welcome to our Annual Himss Orlando 2020 Survey

The cancellation of this year’s HIMSS – has left a hole for many vendors, as to how to reach out to their necessary market, and the reverse, how can hospitals and clinicians follow what is going on?

Every year we receive about one hundred or so requests for interviews and editorials, from PR companies and their healthcare clients. We take here what we feel are the most interesting of these and most relevant, and simply tell it like it is. We publish what they themselves have to say. And we invite you to make direct contact with the vendors concerned. Access to our report will cost you around $2.00, which gos towards our costs of putting the data together for you. And you can use our search bar on our site, to find any topic that might not be immediately visible that we might have spoken about here or earlier.

So.. here we go!

WorkJam: fancy a 20-minute chat with Mark Sagurdesky, co-founder and chief product officer at WorkJam, a workforce management platform used by health providers? Mark will be at HIMSS20 in March. 

Long hours, overnight shifts and stressful work environments have long made healthcare a demanding profession – often resulting in burnout among workers, meaning increased staff turnover and decreased productivity. And while in recent years, hospitals, health systems and advocacy groups have tried to curb the problem, high rates of burnout still persist among the medical community.

With this in mind, healthcare providers must be prepared to reduce additional stress put on associates, or risk losing some of their most valuable team members. Here are a few topics Mark can discuss:

* Ways to prep and communicate with staff during an epidemic, such as the flu or coronavirus
* How to prevent and combat burnout among nurses and other associates
* Strategies healthcare providers can use to support nurses during busy seasons
* Workforce management strategies for retaining healthcare associates.

Addison, the Virtual Caregiver™, will be presented for the first time at HIMSS20. Developed by Electronic Caregiver, a 24/7 virtual care and health technology company, Addison is the game-changing solution to America’s caregiver crisis.

As the caregiver gap continues to widen, an alarming number of people will not be able to rely on loved ones to care for them in old age. According to the AARP Public Policy Institute, the population aged 45 to 64, the peak caregiving age group, is expected to increase by just 1 percent by 2030, while the population aged 80 and older will rise by a substantial 79 percent.

Not only will there be less caregivers, but an AARP study, Family Caregiving and Out-of-Pocket Costs, showed that  unpaid family caregivers spend, on average, nearly 20 percent of their personal income on out-of-pocket costs related to caring for a loved one.

Addison, a state-of-the-art, 3D animated caregiver, is designed to help fill in the gaps when a caregiver can’t be there, trimming health-related expenses and offering support for seniors and those living with chronic conditions.

CredSimple is a New York-based health-tech software company focused on credentialing, provider data, and compliance for healthcare organizations. CredSimple announced last month its acquisition of Glenridge Health, a premier technology-enabled provider network management solutions company – which now makes the company a complete end to end solution for network management for some of the biggest health care providers like Oscar and Clover. CredSimple has experienced explosive growth with 2x revenue growth each year for the past three years— and with this acquisition they are well situated to corner the marketplace.

The Macadamian company has written to us about Voice and AI. What they say is this….AI in Medical Imaging and in combination with technology such as Voice Assistants will transform healthcare workflows to the benefit of patients and clinicians alike, whilst reducing costs.

They say you can learn more at these sessions at HIMSS20:

1.Transforming Medical Imaging with Artificial Intelligence March 10th, 1:30 PM | Leadership Theater, Intelligent Health Pavillon Booth 7273
Timon LeDain, Director of Emerging Technologies, Macadamian, and Mads Jarner Brevadt, CEO Radiobotics

Commercializing AI-enabled digital health tools is a complex process. Referencing a recent solution Macadamian developed with Danish consortium partners Radiobotics and the Bispebjerg Hospital, the considerations, and lessons learned in designing, developing and undergoing clinical validation of an AI-enabled clinical decision support system will be discussed.

2. Why Great Voice AI Means Putting AI Last;
March 11th, 11:30 AM | Innovation Theater, Intelligent Health Pavillon Booth 7273 | Scott Plewes, VP User Experience & Analytics

Voice Assistant-enabled digital health solutions have already proven to benefit healthcare and evolving AI capabilities will only make them better. Still, solutions can have “great” AI and bad results. We’ll share overlooked considerations and common mistakes you need to take into account before you develop your voice AI solution.

There has been a lot of hype around the transformative nature of AI in healthcare, yet both providers and vendors are still in the midst of determining both practical use cases and how to assess and test AI algorithms to ensure the safety and efficacy of the solutions they are being integrated into.

Live demos in the Intelligent Health Pavillion
The following demos will be showcased in a guided tour that will take place throughout the day.
Chronic Disease Patient Management Platform – MiCare allows patients with managing chronic disease to track their symptoms over time with the aim to help them identify behaviors that improve or mitigate their symptoms. Clinicians on the platform can get an overview of their patients’ progress to help them identify what to focus on next in their treatment plan.

Alexa-Enabled Virtual Coaching for Diabetes Management – Macadamian’s My Diabetes Coach is a voice-first diabetes management solution that leverages a breadth of patient data to deliver automated coaching that helps a patient with diabetes better manage their condition. It also connects them with their care team and can support escalation to a diabetes educator via secure messaging.

Cloud-Based Medical Imaging Collaboration Tool – The Clini-Share portal provides a streamlined approach to diagnose patients with rare diseases. Clini-Share assembles de-identified patient MRIs, genetic information and pathology images to improve diagnosis and provide objective imaging biomarkers of disease progression and response to treatment.

Alexa Voice Control in the Operating Room: Improving Efficiency – During surgery, surgeons sometimes have requirements for additional equipment, or other items to be brought into the OR, and rely on the circulating nurse to gather these items. Being able to communicate with the circulating nurse after they have left the OR would be beneficial. The OR Alexa voice skill enables a user to speak a free form request that would be converted from speech to text and then sent to a mobile device carried by the circulating nurse.

Macadamian will be demoing their new Macadamian HealthConnect Platform as a Service that helps enable MedTech and Pharma digital innovation product development teams to accelerate the development of secure and scalable digital therapeutics, digital health applications and software-as-a-medical-device products.

We were very interested to read the following news from Annika Haberland talking about wearable remote data devices. This fits a growth in devices for such areas as clinical ECG monitoring etc. Expect to see more. What she says is;

BioIntelliSense, Inc., a continuous health monitoring and clinical intelligence company, today announces the U.S. commercial launch of its medical grade Data-as-a-Service (DaaS) platform and FDA 510(k) clearance of the BioSticker™ on-body sensor for scalable remote care. BioIntelliSense offers a new standard for Remote Patient Monitoring (RPM) by combining an effortless patient experience with medical grade clinical accuracy and cost-effective data services.

The BioSticker is an advanced on-body sensor that allows for effortless continuous monitoring of vital signs and actionable insights, delivered to clinicians from patients in the home setting, thereby creating unique opportunities for early detection of potentially avoidable complications. Through the platform’s data sets and analytics, highly-efficient care is now possible at a fraction of the cost of traditional remote patient monitoring.

“We are at the inception of a remarkable new era in healthcare that will employ medical grade sensor technologies to effortlessly capture remote patient data and generate personalized clinical intelligence,” said James Mault, MD, FACS, CEO of BioIntelliSense.

BioIntelliSense is built on the foundation of a sophisticated team of engineers and data scientists with decades of expertise in wearable sensor development. With these distinctive capabilities and proprietary technologies, the company is poised to help transform care delivery under the leadership of Dr. Mault, an industry veteran who has an accomplished business and clinical career that has culminated in a number of successful connected health ventures.

BioIntelliSense has established a strategic collaboration with UCHealth and its CARE Innovation Center to demonstrate the value and clinical applications of the BioSticker device and medical-grade services. This alliance is committed to developing and validating new models of data-driven care that are patient-centered and built for scale.

“The future of healthcare will see the lines blurred between the hospital, clinic and home,” said Dr. Richard Zane, UCHealth Chief Innovation Officer and Chair of Emergency Medicine at the University of Colorado School of Medicine. “The use of the BioSticker device for continuous health monitoring enables us to monitor a patient in their home and recognize when a patient may have an exacerbation of illness even before they manifest symptoms. This may reduce hospitalizations, emergency department visits and shorten hospital stays, creating cost efficiencies for health systems.”

—————————

And Axel Wirth of the Medcrypt company, is leading a session Cybersecurity: To be Proactive or Reactive, that is the Question, on. 1:15pm – 2:00pm Thursday, March 12, at Hall A – Booth 400 – Cybersecurity Theater A. What he will discuss is:

“Building a capable security organization and infrastructure is often driven by trade-off decisions and compromise. How does one achieve optimal security by balancing investment into technology vs. process? “ Using the industry’s current approach to securing medical devices as an example, this session will analyze current capabilities and examine evidence on whether we are on the right track or if an adjustment of our strategy is required.
The aim is to discuss the current approach to securing our medical device ecosystem identify, based on subjective evidence, the strength and weaknesses of the current industry strategy, and describe how to differentiate the advantages and disadvantages of the respective elements used.

 

ends.

As said generally, we at ProfoMedia make no endorsement of any of the above – but we recognise the need for any vendor to have airtime and visibility. We are pleased to help where we can.

Is AI finally getting traction in Healthcare?

Ahead of Rare Disease Day (Feb 29), Ashley Yum has written to us,  to offer us the opportunity to speak with Steve Costalas, CEO, HVH Precision Analytics, about how AI and machine learning are being used to help diagnose rare diseases faster and more accurately.

HVH Precision Analytics is a joint venture between the world’s largest health and wellness network Havas Health & You , and Vencore,  and specializes in AI and machine learning data analytics.

At a time when take up of AI in healthcare is surprisingly low, this collaboration is looking at  how AI/big data can identify symptoms of disease 3-5 years before diagnosis, – and using RWD and RWE to find undiagnosed patients in healthcare databases – and finally, – · leveraging data to support the rare disease community beyond diagnosis.

And they have some interesting side announcements, if you will…

95% of rare diseases do not have an FDA-approved treatment, significantly limiting treatment options for the 400 million people living with a rare disease.

7,000 rare diseases have been identified, but only 5% have FDA-approved treatments.

The total number of Americans living with a rare disease is estimated at between 25-30 million.

The average time it takes for rare disease patients to receive an accurate diagnosis is 4.8 years.

However, they are  excited about the progress that’s been made in recent years thanks to AI, and  they would love to share  what they  think is in store for the future.

Ashley can be contacted at; ashley.yum@HVHprecision.com